Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division
  • Business Sort descending
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Business Sort descending Functional Area Erscheinungsdatum
Procure to Pay Business Partner GDD and M&A SPOC INSURGENTES Mexiko Operations CTS Audit und Finanzen Sep 27, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit und Finanzen Okt 06, 2024
Analyst - SFE Products Hyderabad (Office) Indien Operations CTS Marketing Mai 20, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit und Finanzen Jun 26, 2024
Analyst - SFE Products Hyderabad (Office) Indien Operations CTS Marketing Mai 20, 2024
Manager, Analytical Product Services Hyderabad (Office) Indien Operations CTS Marketing Okt 17, 2024
IT Business Partner Director for Clinical Development Barcelona Gran Vía Spanien Operations CTS Technology Transformation Okt 17, 2024
Manager, Analytical Product Services Hyderabad (Office) Indien Operations CTS Marketing Okt 17, 2024
Senior Specialist DDIT ISC Detection & Response Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 17, 2024
Associate Director, Enterprise Architect Network Security Barcelona Gran Vía Spanien Operations CTS Technology Transformation Okt 16, 2024
Human Resources Services Expert with German Prague Tschechische Republik People & Organization CTS Humanressourcen Okt 16, 2024
Comms & Engagement Manager Amsterdam Niederlande Corporate Affairs CTS Communications & Public Affairs Okt 16, 2024
Executive Director, Therapy Area Communications and Patient Advocacy Basel (City) Schweiz Corporate Affairs CTS Communications & Public Affairs Okt 16, 2024
H2R Services Expert Moscow (City) Russische Foed. People & Organization CTS Humanressourcen Okt 16, 2024
Manager - FC&C Hyderabad (Office) Indien Finance CTS Audit und Finanzen Okt 16, 2024
Sr. Spec. DDIT IES NW Engg Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 16, 2024
Senior Analyst Commercial Analytics Hyderabad (Office) Indien Operations CTS Marketing Okt 16, 2024
Associate Director - Technology Modernization(Application Portfolio Management, Project/Program Management) Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 18, 2024
IT Senior Project Manager Barcelona Gran Vía Spanien Operations CTS Technology Transformation Okt 18, 2024
Director of Global & Swiss Media & Editorial Basel (City) Schweiz Corporate CTS Communications & Public Affairs Okt 18, 2024
Sr. Spec. DDIT ISC Gov GxP Assessments Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 18, 2024
Sr. Spec. DDIT IES Supplier Management Hyderabad (Office) Indien Operations CTS Informationstechnologie Okt 18, 2024
Record to Report (R2R) Specialist New Cairo Ägypten Finance CTS Audit und Finanzen Okt 18, 2024
Record to Report (R2R) Section Head New Cairo Ägypten Finance CTS Audit und Finanzen Okt 18, 2024
Sr. Spec. Solution Delivery HCM Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 18, 2024
Treasury Cash Management Payment Specialist INSURGENTES Mexiko Finance CTS Audit und Finanzen Okt 16, 2024
Associate Director, QC IT Solution Delivery Ljubljana Slowenien Operations CTS Technology Transformation Okt 16, 2024
Associate Director QC IT - LIMS Master Data Governance Ljubljana Slowenien Operations CTS Technology Transformation Okt 16, 2024
Associate Director, Corporate Event Marketing Cambridge (USA) USA Corporate Affairs CTS Communications & Public Affairs Okt 16, 2024
Director - LDC Business and IT Controls(SAP S/4 Hana) Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 16, 2024
PS&S Engagement Services Expert INSURGENTES Mexiko People & Organization CTS Humanressourcen Okt 16, 2024
Human Resources Specialist (5 Temporary roles -12 months) INSURGENTES Mexiko People & Organization CTS Humanressourcen Okt 16, 2024
Consultant, Evidence Generation Hyderabad (Office) Indien Operations CTS Market Access Okt 16, 2024
Manager Economic Modelling Hyderabad (Office) Indien Operations CTS Market Access Okt 16, 2024
Financial IT Compliance Senior Specialist London (The Westworks) Tschechische Republik Finance CTS Audit und Finanzen Okt 17, 2024
Manager - Advanced Patient Analytics Hyderabad (Office) Indien Operations CTS Marketing Okt 16, 2024
Financial IT Compliance Manager London (The Westworks) Tschechische Republik Finance CTS Audit und Finanzen Okt 17, 2024
Vodja Finančne skladnosti in kontrol Slovenija (m/ž/d) / Financial Control and Compliance Lead Slovenia (m/f/d) Ljubljana Slowenien Finance CTS Audit und Finanzen Okt 17, 2024
Sr. Specialist DDIT ISC Detection & Response Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 17, 2024
Interim HR System Expert Milano Italien People & Organization CTS Humanressourcen Okt 17, 2024
Manager, Corporate Marketing Creative & Design East Hanover USA Corporate Affairs CTS Communications & Public Affairs Okt 17, 2024
Assistant Manager - FC&C Hyderabad (Office) Indien Finance CTS Audit und Finanzen Okt 17, 2024
P2P Process Excellence INSURGENTES Mexiko Operations CTS Audit und Finanzen Okt 02, 2024
Global FC&C Process Expert (Senior Manager) PIN-PCA Prague Tschechische Republik Finance CTS Audit und Finanzen Okt 03, 2024
P2P Service Delivery (SD) Lead NGSC INSURGENTES Mexiko Finance CTS Audit und Finanzen Okt 07, 2024
Finance Control and Compliance US Manager INSURGENTES Mexiko Finance CTS Audit und Finanzen Okt 08, 2024
General Accounting Manager INSURGENTES Mexiko Finance CTS Audit und Finanzen Okt 09, 2024
Learning & Talent Central Services Specialist INSURGENTES Mexiko People & Organization CTS Humanressourcen Okt 14, 2024
Coordinator, Global Program Management and Portfolio Excellence INSURGENTES Mexiko Biomedical Research CTS Research & Development Okt 15, 2024
Procure to Pay Business Partner Management INSURGENTES Mexiko Finance CTS Audit und Finanzen Okt 16, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.